"Completeness of Response" Following Treatment With Treximet™ for Migraine
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
Many clinical trials may not fully explore criteria that are important to some migraine
patients' definition of "complete response." This study offers the opportunity to evaluate
the effectiveness of Treximet™ when non-standard criteria are examined (for example, neck
pain, irritability or fatigue). Subjects enrolled at 8 investigative sites will complete 2
visits. Subjects will complete a Completeness of Response Survey at Visit 1 considering their
usual migraine medication (a triptan) and a Completeness of Response Survey at Visit 2
considering their study medication (Treximet™).